Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.71 |
| ▸ | CA12 | O43570 | 1/20 | 0.66 |
| ▸ | CA2 | P00918 | 1/20 | 0.66 |
| ▸ | CA9 | Q16790 | 1/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4581466 | 1.00 | ALDH1A1 (0.71) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL12691657 | 0.94 | ALDH1A1 (0.63) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL12629240 | 0.92 | ALDH1A1 (0.61) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL13955399 | 0.89 | ALDH1A1 (0.58) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL14139848 | 0.87 | ALDH1A1 (0.56) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL12629636 | 0.86 | ALDH1A1 (0.71) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL6130639 | 0.86 | CA12 (0.81) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL6354094 | 0.85 | ALDH1A1 (0.66) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL5567042 | 0.85 | ALDH1A1 (0.75) | ALDH1A1CA12CA2CA9ALOX15 | |
| SCHEMBL565872 | 0.84 | ALDH1A1 (0.60) | ALDH1A1CA12CA2CA9ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084303-A1 | Complexes and Ligands | THE GENERAL HOSPITAL CORPORATION | 2025-03-13 | — | — | US | disclosed |
| US-12134721-B2 | Complexes and ligands | THE GENERAL HOSPITAL CORPORATION (US) | 2024-11-05 | — | — | US | disclosed |
| EP-4424686-A1 | COMPLEXES AND LIGANDS | The General Hospital Corporation (US) | 2024-09-04 | — | — | EP | disclosed |
| EP-3870044-B1 | COMPLEXES AND LIGANDS | MASSACHUSETTS GEN HOSPITAL (US) | 2024-04-10 | — | — | EP | disclosed |
| US-20220025254-A1 | Complexes and Ligands | THE GENERAL HOSPITAL CORPORATION | 2022-01-27 | — | — | US | disclosed |
| EP-2423201-B1 | Luminescent macrocyclic lanthanide complexes | UNIV CALIFORNIA (US) | 2017-10-04 | — | — | EP | disclosed |
| US-8729258-B2 | Luminescent macrocyclic lanthanide complexes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-05-20 | — | — | US | disclosed |
| US-8729258-B2 | Luminescent macrocyclic lanthanide complexes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-05-20 | — | — | US | disclosed |
| US-20120329174-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-12-27 | — | — | US | disclosed |
| US-20120329174-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-12-27 | — | — | US | disclosed |
| US-8173800-B2 | Hydroxy-isophthalamide moieties; antibodies; high stability, luminescence; kits | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-05-08 | — | — | US | disclosed |
| US-8173800-B2 | Hydroxy-isophthalamide moieties; antibodies; high stability, luminescence; kits | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-05-08 | — | — | US | disclosed |
| EP-2423201-A1 | Luminescent macrocyclic lanthanide complexes | The Regents of The University of California (US) | 2012-02-29 | — | — | EP | disclosed |
| US-20080213917-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-09-04 | — | — | US | disclosed |
| WO-2008063721-A2 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080213917-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | SSB, HACD3, CLTA | ALDH1A1 4586/4885CA12 541/4885CA2 490/4885 |
| US-20120329174-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | SSB, HACD3, CLTA | ALDH1A1 4586/4885CA12 541/4885CA2 490/4885 |
| US-20250084303-A1 | Complexes and Ligands | BID, CLTB, NECTIN4 | ALDH1A1 3131/4885CA12 335/4885CA2 2677/4885 |
| US-20220025254-A1 | Complexes and Ligands | BID, CLTB, NECTIN4 | ALDH1A1 3131/4885CA12 335/4885CA2 2677/4885 |
| US-12134721-B2 | Complexes and ligands | BID, CLTB, NECTIN4 | ALDH1A1 3131/4885CA12 335/4885CA2 2677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.